ESH Video

22nd Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy

22nd Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
October 02 - October 04, 2020 - Mandelieu-La Napoule, France
Chairs : Jorge Cortes, Tim P. Hughes, Daniela S. Krause


22nd Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
October 2-4, 2020 – Mandelieu-La Napoule, France

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause 

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

The Program will include

  • John Goldman Prize

  • Janet Rowley Prize

  • iCMLf Prize

  • Keynote lectures

  • Special lectures

  • Oral communications selected from submitted abstracts

  • Brief oral communications selected from submitted abstracts

  • Workshops for non-clinical scientists

  • Meet-the-Expert Sessions

  • Clinical and biology manned poster walks

  • 2020 Saturday Clinical symposium 

  • Satellite symposia


  • The 2nd annual ESH John Goldman International Research Award will be presented and the awardee will give a plenary presentation during the meeting.

Access the Call for Applications here

Deadline for Submission: March 1, 2020


Educational Objectives: 

Upon completion of this CME activity, participants should be able to:

1. Understand current and new concepts of the signal transduction pathways involved in chronic myeloid leukemia (CML) and the mechanisms of action of tyrosine kinase inhibitors and other new agents.

2. Have insight into the possible mechanisms of genomic instability that predisposes to formation of the BCR-ABL fusion gene and predispose also to disease progression and the consequences of such instability.

3. Define a leukemia stem cell and its relationship to disease kinetics in so far as current knowledge permits.

4. Evaluate the merits of various management decisions, e.g. how to start treatment for patients in the different phases of CML, how to assess success or failure of initial treatment, what approaches to consider for patients who have failed to respond well to initial treatment, including assessing the precise role of second and third generation TKIs and other non-molecular therapeutic approaches.

5. Review the current recommendations and discuss current concepts and challenges of monitoring individual patients with hematologic, cytogenetic and molecular (RQ-PCR) methods.

6. Assess the role of allogeneic stem cell transplantation in the management of CML.

7. Critically evaluate the possible role of the different immunotherapeutic approaches in the treatment of CML.

8. Discuss current data and ongoing research regarding treatment-free survival as an endpoint in CML management.

9. Discuss patient reported outcomes and their role in the management of patients with CML.




Abstract submission


MAY 8th, 2020




Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 400
– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).



To book a room, please contact :


Phone : +33(0)4 93 93 64 75  


Centre Expo Congrès Mandelieu
806 Avenue de Cannes
06210 Mandelieu-La Napoule

Corporate partners

With the support of*

Emerald Conference Partner



*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.



The present Call for Applications may be of interest to you if you are:

  • fully trained, with a maximum of 4 years of experience since your first junior faculty appointment
  • still in training

Click here for more information and to download the Application form.
Deadline for applications: May 8, 2020

For more information please contact:


The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
– ESH independently ensures all scientific peer review and selection procedures.
– ESH is also independently responsible for all administrative aspects of the Fund.



Educational Grants


The registration fee for this conference:

– Regular registration fee: 600€

– Registration fee for Corporate: 730€

– Registration fee for resident in-training: 300€ (support document required)

– Registration fee for Allied Health Professional (Nurse, Pharmacist, Lab Technician, etc): 300€


This fee includes :
Your place in the Conference Room,
Conference Materials,
Luncheons, Refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

How to proceed :
Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

A) For Individual Registration:
1. Click on REGISTER HERE at the bottom of the page
3. Create an account and complete the registration form. It is very important to use the email of the participant in the form.
4. Proceed with the payment.

B) For Group Registration (More than one person):
1. Click on REGISTER HERE at the bottom of the page
3. Create an account and fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)
4. Proceed with payment.

Cancellation policy of registration fee
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA, MASTERCARD/EUROCARD, AMEX and CB.